Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

AVTXAVTX
4 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in AVALO THERAPEUTICS INC

BALYASNY ASSET MANAGEMENT L.P. holds 861,711 shares of AVTX (AVALO THERAPEUTICS INC), worth $15.9M as of 2026-Q2. The position was increased (+17.8% shares). AVTX represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$15.9M

Current Shares

861,711

Total Value Change

+$5.5M

Total Shares Change

+44,275

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
861,711
+17.8%
$15.9M0.0%$18.48
33
2026-Q1
Increased
731,586
+66.5%
$10.9M0.0%$18.85
41
2025-Q4
Decreased
439,312
-46.3%
$8M0.0%$17.81
0
2025-Q3
New
817,436
-
$10.4M0.0%$13.02
38

Other major holders of AVTX: FMR LLC, BlackRock, Inc., STATE STREET CORP, FARALLON CAPITAL MANAGEMENT, L.L.C., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used